19-norprogesterone
19-Norprogesterone[edit | edit source]
19-Norprogesterone is a synthetic progestogen, a type of hormone that is similar to the naturally occurring hormone progesterone. It is characterized by the removal of the methyl group at the 19th carbon position of the progesterone molecule, which significantly alters its biological activity.
Chemical Structure and Properties[edit | edit source]
19-Norprogesterone is a derivative of progesterone, with the chemical formula C20H28O2. The removal of the 19-methyl group results in a compound that has different binding affinities and activities at the progesterone receptor compared to natural progesterone.
Mechanism of Action[edit | edit source]
19-Norprogesterone acts primarily by binding to the progesterone receptor in target tissues. This binding leads to changes in gene expression that are responsible for the progestogenic effects, such as the regulation of the menstrual cycle and maintenance of pregnancy.
Clinical Uses[edit | edit source]
While 19-norprogesterone itself is not commonly used in clinical practice, its derivatives, such as norethisterone and norgestrel, are widely used in hormonal contraceptives and hormone replacement therapy. These derivatives are more potent and have better oral bioavailability than natural progesterone.
Pharmacokinetics[edit | edit source]
The pharmacokinetics of 19-norprogesterone and its derivatives can vary significantly. They are generally well absorbed when administered orally, but their metabolism and elimination can be influenced by factors such as liver function and the presence of other medications.
Side Effects[edit | edit source]
The side effects of 19-norprogesterone derivatives can include changes in menstrual bleeding patterns, weight gain, mood changes, and an increased risk of thromboembolic events. These side effects are similar to those observed with other progestogens.
Research and Development[edit | edit source]
Research into 19-norprogesterone and its derivatives continues, with a focus on developing new compounds with improved efficacy and safety profiles. These efforts aim to enhance the therapeutic options available for conditions such as endometriosis, polycystic ovary syndrome, and menopausal symptoms.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD